EUVIMEDSkopri EUVIMED
Crossref

Gonadotropin axis and semen quality in young Swiss men after cannabis consumption: Effect of chronicity and modulation by cannabidiol

Fanny Zufferey iD, Elina Buitrago, Rita Rahban, Alfred Senn, Eric Stettler, Serge Rudaz, Serge Nef iD, Nicolas Donzé, Aurélien Thomas, Michel F Rossier

Andrology · 2024

DOI: 10.1111/andr.13440 ↗

At a glance

Journal article in Andrology, 2024. Written by Fanny Zufferey and 9 co-authors. Institution: Service of Clinical Chemistry and Toxicology, Central Institute of Hospitals, Hospital of Valais, Sion, Switzerland. Major MEDLINE topics: Cannabis, Cannabidiol. Cited 10 times so far (Crossref); 42 references. Funded by: Swiss Centre for Applied Human Toxicology, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Background

While cannabis is the most widely used recreational drug in the world, the effects of phytocannabinoids on semen parameters and reproductive hormones remain controversial. Cannabinoid receptors are activated by these compounds at each level of the hypothalamus–pituitary–gonadotropic axis.

Objectives

To assess the impact of the consumption of Δ‐9‐tetrahydrocannabinol and cannabidiol on semen parameters, as well as on male reproductive hormone and endocannabinoid levels, in a cohort of young Swiss men. Materials and methods The individuals in a Swiss cohort were divided according to their cannabis consumption. In the cannabis user group, we determined the delay between the last intake of cannabis and sample collection, the chronicity of use and the presence of cannabidiol in the consumed product. Urinary Δ‐9‐tetrahydrocannabinol metabolites were quantified via gas chromatography–mass spectrometry. Blood phytocannabinoids, endocannabinoids and male steroids were determined via liquid chromatography–mass spectrometry/mass spectrometry, and other hypothalamus–pituitary–gonadotropic axis hormones were determined via immunoassays. Semen parameters such as sperm concentration and motility were recorded using computer‐assisted sperm analysis.

Results

Anandamide, N‐palmitoyl ethanolamide, androgens, estradiol and sex hormone binding globulin levels were all higher in cannabis users, particularly in chronic, recent and cannabidiol‐positive consumers. Gonadotropin levels were not significantly different in these user subpopulations, whereas prolactin and albumin concentrations were lower. In addition, cannabis users had a more basic semen pH and a higher percentage of spermatozoa with progressive motility. However, the two latter observations seem to be related to a shorter period of sexual abstinence in this group rather than to the use of cannabis.

Conclusions

Because both cannabidiol and Δ‐9‐tetrahydrocannabinol are frequently used by men of reproductive age, it is highly relevant to elucidate the potential effects they may have on human reproductive health. This study demonstrates that the mode of cannabis consumption must be considered when evaluating the effect of cannabis on semen quality.

Subjects

MeSH terms (MEDLINE)

CannabisCannabidiolHumansMaleSemen AnalysisDronabinolSwitzerlandSeedsProlactin

Author keywords

CBDHPG axisTHCendocannabinoidsestradiolgonadotropinssemen qualitytestosterone

Substances

CannabidiolDronabinolProlactin

Authors and institutions

  • Service of Clinical Chemistry and Toxicology, Central Institute of Hospitals, Hospital of Valais, Sion, Switzerland.
  • Department of Genetic Medicine and Development, University of Geneva, Geneva, Switzerland.
  • School of Pharmaceutical Sciences, Universities of Geneva and Lausanne, Geneva, Switzerland.
  • Forensic Toxicology and Chemistry Unit, CURML, Lausanne University Hospital, Geneva University Hospital, Geneva, Switzerland.
  • Faculty Unit of Toxicology, CURML, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.
  • Department of Internal Medicine, Geneva University Faculty of Medicine, Geneva, Switzerland.

ORCID profiles: Fanny Zufferey, Serge Nef

Funding

  • Swiss Centre for Applied Human Toxicology
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Cite

APA

Zufferey, F., Buitrago, E., Rahban, R., Senn, A., Stettler, E., Rudaz, S., Nef, S., Donzé, N., Thomas, A., & Rossier, M. F. (2024). Gonadotropin axis and semen quality in young Swiss men after cannabis consumption: Effect of chronicity and modulation by cannabidiol. Andrology. https://doi.org/10.1111/andr.13440

Vancouver

Zufferey F, Buitrago E, Rahban R, Senn A, Stettler E, Rudaz S, et al. Gonadotropin axis and semen quality in young Swiss men after cannabis consumption: Effect of chronicity and modulation by cannabidiol. Andrology. 2024. doi:10.1111/andr.13440

BibTeX
@article{Zufferey2024,
  author = {Zufferey, Fanny and Buitrago, Elina and Rahban, Rita and Senn, Alfred and Stettler, Eric and Rudaz, Serge and Nef, Serge and Donzé, Nicolas and Thomas, Aurélien and Rossier, Michel F},
  title = {Gonadotropin axis and semen quality in young Swiss men after cannabis consumption: Effect of chronicity and modulation by cannabidiol},
  journal = {Andrology},
  year = {2024},
  doi = {10.1111/andr.13440}
}
Start for free →